Resource Centre
Global Industry Report:
In a recent Pharma IQ study, conducted ahead of the Global Formulation and Drug Delivery Summit in April 2012 in Amsterdam, it was clear that the majority of organisations are focusing on the less expensive of the two, drug formulation. Read further to find out what do your colleagues consider to be the greatest challenges within drug development
Formulation and Drug delivery report
Featured Podcast
Predictions for Targeted Drug Delivery with David Elder and Brendan Griffin
In this Pharma IQ interview David Elder, Director of Product Development, GlaxoSmithKline and Brendan Griffin Lecturer in Pharmaceutics and Course Director University College Cork, discuss how they are tackling major challenges in drug development, such as improving solubility to enhance bioavailability and overcoming poor compound stability. They also share their thoughts on the latest developments in micro and nanoparticle technology and how can they be used for targeted drug delivery and make predictions for the next biggest innovation in targeted drug delivery. Finally they discuss the recent impact of the economic climate and how especially in these unstable economic times academia and industry should work together in drug development collaborations
Podcasts
Oral Lipid Formulations - Enhancing the Bioavailability of Poorly Water Soluble Drugs
Lipid formulations have gained momentum in recent years as an efficient means for improving solubility of new chemical entities, but ensuring the stability of these systems can prove challenging. Learn more
How to Avoid Common Pitfalls in Formulation
"I think not knowing what you want to outsource is one of the major pitfalls. I think for me it’s key that you define internally what is your target product profile and what you want to outsource. By this I think you can avoid most of the pitfalls of outsourcing," said Martin Schubert, Formulation Group Leader at UCB. Learn more
Big Formulation Breakthroughs
David Elder, Externalisation Director for GlaxoSmithKline and Pharma IQ Advisory Board Member, joins Andrea Charles from Pharma IQ, to discuss the most critical unmet drug delivery need and the benefits of early formulation testing. Elder shares his insights on how he thinks formulation screening and testing will develop in the next five years and what will be the next big thing in the field.
Why Changes are needed to Current Preformulation and Formulation Practices
As part of the Pharma Leaders Today Series Dr. Keith Horspool, Vice President, Pharmaceutical Development US, Boehringer Ingelheim, speaks to Andrea Charles from Pharma IQ, about why changes are needed to current preformulation and formulation practices, strategies to reduce time spent in R&D and importance of the role of co-crystals in formulation design and product development. Horspool also shares his top 3 tips for evaluating the potential of new drug delivery technologies.
Pharma Bytes: Interview with Per Holm of Lundbeck
Dr. Per Holm, Chief Specialist Product Development and Lifecycle Lundbeck, joined Pharma IQ for a quick Q&A session on formulation development ahead of the Global Preformulation & Formulation Summit, taking place in Amsterdam from the 11th -13th April 2011. Pharma IQ: Please could you tell us a bit about your current role? P Holm: I am responsible for our drug....Read more
Articles
Formulation Strategy: Five Years From Now Contributor: David Elder
An exclusive report from Dr David Elder, Director, Externalization group (SCINOVO), GlaxoSmithKline on the benefits of employing early formulation testing, how formulation screening and testing will develop in the next 5-years and why Stem Cell Therapies will represent the next big breakthrough...
Driving the success of Pre Formulation and Formulation
The global importance of drug preformulation and formulation
Boosting Bioavailability Through Partnerships
If the trends that have been seen in the pharmaceutical industry over the past few years prove anything, it is that drug development companies are increasingly recognising the value of teamwork. There is plenty of evidence that businesses in the sector are seeing the benefits that partnerships with contract research organisations can offer, at a range of points in the production process. One stag....Read more
3 Tips on Overcoming Poor Aqueous Solubility and Stability
What are the 7 Deadly Sins of Quality Assurance and Quality Control? Download our free QA QC eBook now to find out! Rene Holm, Head of Preformulation at H Lundbeck A/S, joins Pharma IQ to discuss the benefits of early stage preformulation, how advances in drug delivery devices have impacted on formulations, and strategies for enhancing solubility. ....Read more
Applying Biopharmaceutical Nanotechnology to Diagnostics, Drug Discovery and Drug Delivery
The application of nanobiotechnology has far ranging uses within a number of sectors of the life sciences industry, including drug discovery, formulation, clinical assessment, drug delivery and monitoring. A benchmark report on nanotechnology produced in 2002 by CMP Cientifica claimed that nanotechnology will have "a major impact on the medical and pharmaceuticals industry" and since then ....Read more
Three Top Tips for Evaluating the Potential of New Drug Delivery Technologies
Dr. Keith Horspool, Vice President, Pharmaceutical Development US at Boehringer Ingelheim, joins Andrea Charles from Pharma IQ, to discuss strategies to reduce time spent in R&D and recent trends in the adoption of novel drug delivery technologies. Pharma IQ: How has the global market for pharmaceutical R&D evolved in recent years? K Horspool: Clearly it’s a much tougher envi....Read more
White Paper
Ingredients, Process Technology Services and Expertise for Drug Solubility Enhancement